Showing results (91-100 of 300) with videos related to

Sort By:
Pageof 30
Journal of Travel Medicine|March 19, 2008
Attitudes toward predeployment and experimental vaccinations among troops deployed to Operation Iraqi Freedom and Operation Enduring FreedomMark S Riddle, Shimul S Patel, John W Sanders, et al.
Military Medicine|November 29, 2019
Opportunities and Obstacles in the Prevention of Skin and Soft-Tissue Infections Among Military PersonnelEugene V Millar, Carey D Schlett, Natasha N Law, et al.
Plos One|August 29, 2023
Enterobacter cloacae infection characteristics and outcomes in battlefield trauma patientsWilliam Bennett, Katrin Mende, Wesley R Campbell, et al.
Open Forum Infectious Diseases|September 29, 2023
The Impact of Infectious Disease Syndromes on Activities During Military TravelMichael A Boatwright, Huai-Ching Kuo, David A Lindholm, et al.
Military Medicine|February 20, 2020
Antibiotic Practice Patterns for Extremity Wound Infections among Blast-Injured SubjectsLaveta Stewart, Ping Li, Maj Dana M Blyth, et al.
Military Medicine|November 29, 2019
After the Battlefield: Infectious Complications among Wounded Warriors in the Trauma Infectious Disease Outcomes StudyDavid R Tribble, Clinton K Murray, Bradley A Lloyd, et al.
Diagnostic Microbiology and Infectious Disease|December 4, 2019
Stenotrophomonas maltophilia infections: Clinical characteristics in a military trauma populationShane B Patterson, Katrin Mende, Ping Li, et al.
Vaccine|April 3, 2022
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trialJessica W Crothers, Elizabeth Ross Colgate, Kelly J Cowan, et al.
Surgical Infections|June 5, 2018
Early Infections Complicating the Care of Combat Casualties from Iraq and AfghanistanAmy C Weintrob, Clinton K Murray, Jiahong Xu, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacinShannon D Putnam, John W Sanders, David R Tribble, et al.
Pageof 30